0001753926-24-000984.txt : 20240515
0001753926-24-000984.hdr.sgml : 20240515
20240515163919
ACCESSION NUMBER: 0001753926-24-000984
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240514
FILED AS OF DATE: 20240515
DATE AS OF CHANGE: 20240515
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaufman Jonathan H
CENTRAL INDEX KEY: 0001959250
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41575
FILM NUMBER: 24951958
MAIL ADDRESS:
STREET 1: C/O LIPELLA PHARMACEUTICALS INC.
STREET 2: 7800 SUSQUEHANNA ST., SUITE 505
CITY: PITTSBURGH
STATE: PA
ZIP: 15208
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIPELLA PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0001347242
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 N LEXINGTON ST
STREET 2: STE LL103
CITY: PITTSBURGH
STATE: PA
ZIP: 15208
BUSINESS PHONE: 412-901-0315
MAIL ADDRESS:
STREET 1: 400 N LEXINGTON ST
STREET 2: STE LL103
CITY: PITTSBURGH
STATE: PA
ZIP: 15208
FORMER COMPANY:
FORMER CONFORMED NAME: LIPELLA PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20051219
4
1
ownership.xml
X0508
4
2024-05-14
0
0001347242
LIPELLA PHARMACEUTICALS INC.
LIPO
0001959250
Kaufman Jonathan H
C/O LIPELLA PHARMACEUTICALS INC.
7800 SUSQUEHANNA ST., SUITE 505
PITTSBURGH
PA
15208
1
1
1
0
See remarks below.
0
Common Stock
2024-05-14
4
P
0
10000
0.759
A
898849
D
Open market purchase by the reporting person of 10,000 shares of common stock, par value $0.0001 per share (the "Common Stock").
Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on May 14, 2024 at prices ranging from $0.7552 to $0.76 per share, inclusive. The amount reflected has been rounded to 3 decimal points.
The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.
President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors
/s/ Jonathan H. Kaufman
2024-05-15